Clinical Trial Update: Cyclophosphamide for Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for cyclophosphamide in recurrent/stage IV nasopharyngeal undifferentiated carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Undifferentiated Carcinoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: The University of Hong Kong | Conditions: Recurrent Nasopharyngeal Undifferentiated Carcinoma, Stage IV Nasopharyngeal Undifferentiated Carcinoma | Phase 2 | Status: COMPLETED